Canada markets closed

JNJ Jan 2025 230.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.02000.0000 (0.00%)
As of 12:10PM EDT. Market open.
Full screen
Previous Close0.0200
Open0.0200
Bid0.0000
Ask0.0800
Strike230.00
Expire Date2025-01-17
Day's Range0.0200 - 0.0200
Contract RangeN/A
Volume1
Open Interest487
  • Yahoo Finance Video

    UnitedHealth, Walgreens, J&J: Health earnings in focus

    Johnson & Johnson (JNJ), UnitedHealth Group (UNH), and Walgreens Boots Alliance (WBA) all reported earnings on Tuesday. To break all these earnings results down, Yahoo Finance senior health reporter Anjalee Khemlani joins Julie Hyman and Josh Lipton on Market Domination. Khemlani notes UnitedHealth's disappointing outlook as the health insurer contends with Medicare Advantage's latest coverage terms; Walgreens topped its fiscal fourth quarter estimates while planning to close 1,200 stores over the next three years; lastly, pharmaceutical giant J&J beat its earnings and revenue estimates. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Luke Carberry Mogan.

  • Yahoo Finance Video

    Bank of America, Q3 earnings, Fedspeak: What to Watch

    Bank of America (BAC), Goldman Sachs (GS), and Citigroup (C) are among the next round of Big Banks to report corporate earnings, due out on Tuesday, October 15. Other notable companies reporting their third quarter earnings include UnitedHealth Group (UNH), Johnson & Johnson (JNJ), and Albertsons (ACI). Lastly, Federal Reserve Governor Adriana Kugler is set to release commentary tomorrow, with Wall Street listening closely for any clues to the central bank's next interest rate move in November. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here. This post was written by Luke Carberry Mogan.

  • Investor's Business Daily

    J&J Stock Leapfrogs 50-Day Line After Health Care Titan Raises Sales Outlook

    Johnson & Johnson stock rose Tuesday after the company beat Wall Street's third-quarter expectations, but cut its full-year profit forecast.